Fast Melt Tablet Market

Fast Melt Tablet Market Outlook (2024 to 2034)

The global fast melt tablet market is estimated to reach a valuation of US$ 16.9 billion in 2024 and further expand at a CAGR of 8.1% to achieve a size of US$ 36.68 billion by 2034-end.

Fast melting tablets are a form of medicine that dissolves in the mouth without chewing. In today's world, it's common to live a hectic lifestyle, due to this the demand for fast melt tablets is increasing among working-class people who don't have access to water all the time. Young people, the elderly, and those who are ill and bedridden are a few of the other class of segments that desire such tablets.

These tablets are easy to manufacture, thus allowing manufacturers to complete the operations and fulfill consumer demand. Key players in the market are actively seeking out government contacts to get the required legal licenses and approval, which is hindering market growth.

The rising need for affordable goods and patient cooperation to improve the quality of life for patients is also playing a crucial role in increasing sales of such tablets. When utilizing oral solid traditional formulations, there is a risk of suffocation or choking. To avoid these risks, doctors in several cases recommend these fast melt tablets to prevent any further medical complications.

To remain afloat in the market, some key companies are constantly putting efforts into implementing different development tactics. Among the growth methods used by these major firms to prosper in the cutthroat industry are product launches, innovations, mergers and acquisitions, partnerships, and extensive research & development. To provide businesses with the most effective and economical solutions, the major market participants are also continuously committed to research and development.

Report Attribute	Detail
Fast Melt Tablet Market Size (2024E)	US$ 16.9 Billion
Forecasted Market Value (2034F)	US$ 36.68 Billion
Global Market Growth Rate (2024 to 2034)	8.1% CAGR
East Asia Market Growth Rate (2024 to 2034)	9%
North America Market Value (2034F)	US$ 14.24 Billion
NSAIDS Segment Growth Rate (2024 to 2034)	6% CAGR
Retail Pharmacies Segment Value (2034F)	US$ 13.56 Billion
Key Companies Profiled	Teva Pharmaceutical Industries Ltd.; Novartis AG; AstraZeneca; Mylan N.V.; Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Bausch Health; GlaxoSmithKline Plc; Sun Pharmaceutical Industries Ltd.; Bayer AG; Eli Lily and Company; Dr. Reddy’s Laboratories Ltd.; Takeda Pharmaceutical Company Limited; Kissei Pharmaceutical Co. Ltd.

Demand for fast melt tablets was analyzed to observe stable recovery in the short-term, with a positive growth position in the long run. High adoption of fast melt tablet technology is projected to offer lucrative opportunities in the near future.

What are the major drivers of the Fast Melt Tablet Market?

Fast melts tablet is an oral solid dosage form that disintegrates in the oral cavity without water or chewing. Fast or mouth-dissolving tablets have been formulated for active patients who are busy traveling, and do not have access to water, or a patient who is unable to swallow. It is highly adopted by pediatric, geriatric, and bedridden patients.

Because of constant innovations in the field of oral-dissolving drug delivery systems, they are now used for several benefits, such as quick drug therapy intervention, increased bioavailability, good stability, easy manufacturing, united and accurate dosing, easy handling, motion sickness, suede episodes of allergic attack or coughing, where an ultra-rapid onset of action required.

The increase in the elderly population, who are unable to swallow the medicine, and the rise in product promotion aimed at raising awareness of the treatment of patients are creating opportunities, as stated in the fast melt tablet industry analysis. Rise in demand for patient compliance and cost-effective products to improve the quality of patients’ lives.

Due to the administration of oral solid traditional formulations, there is a risk of choking or suffocation. In addition, technological innovations in fast melt tablets meet pharmacopeia requirements where the tablet disperses rapidly before swallowing and disintegrates in less than 3 minutes. This is supporting the market growth.

High Adoption of Fast Melt Tablets Expected to Boost the Demand

High adoption of fast-melt tablets by the geriatric population gives demand progress for the market during the forecast period. First-pass metabolism is a big issue in a conventional oral formulation that is possibly prevented with the help of these tablets, according to the fast melt tablet industry outlook.

These drug delivery systems are capable of achieving patient compliance to a great extent, which boosts the demand. Self-administration is possible with high bioavailability immediate action and decreased side effects of the drug to patients. This is the formulation driving force for more adoption.

However, some technological challenges that create hindrances in this drug delivery system are overcome with extensive research in formulation and development. This adds to the adoption of fast dissolving tablets.

North America Fast Melt Tablet Industry Outlook

Due to the market player innovation, the North American market occupies an essential part of the global demand. The primary factor that makes the North American market the key revenue-generating region in this field is the presence of major companies manufacturing advanced drug delivery systems that are funding several R&D activities for the market.

Along with the above-mentioned factors, the increased disposable income and developments in the healthcare industry are other key factors leading to market position, as per the fast melt tablet industry analysis.

Europe Fast Melt Tablets Demand Outlook

Europe is the second leading region in this field due to the high percentage of geriatric population. According to the research done by Eurostat in 2019, there were 90.4 million older people. The geriatric population is adopting due to swallowing issues, and the gastrointestinal tract is also weak for old age patients, so they adopt faster melt tablets.

In addition, a rising incidence of heart attacks in Europe, so in such cases, fast melt tablets act for quick delivery and immediate action. These are some factors that are driving the fast melt tablet market.

Who are the key players in the Fast Melt Tablet Market?

Some of the manufacturers of fast melt tablets are :

• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• AstraZeneca
• Mylan N.V.
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Bausch Health
• GlaxoSmithKline plc
• Sun Pharmaceutical Industries Ltd.
• Bayer AG
• Eli Lily and Company
• Dr. Reddy’s Laboratories Ltd.
• Takeda Pharmaceutical Company Limited
• Kissei Pharmaceutical Co. Ltd.

For instance, in June 2019, Kissei Pharmaceutical Co., Ltd. launched GLUBES, which is the new orally disintegrating dosage form of GLUBES Combination Tab.

Fast Melt Tablet Market Report Highlights :

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current, and projected industry size and recent industry trends
• Key Competition landscape
• Strategies for key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Segmentation of Fast Melt Tablet Market Research

• By Drug Class :

  • Anti-Psychotics
  • Anti-Epileptics
  • CNS Stimulants
  • Anxiolytics
  • Anti-Parkinsonian Drugs
  • Anti-Hypertensive
  • NSAIDS
  • Anti-Allergy Drugs
  • Proton Pump Inhibitors
  • Others

• By Indication :

  • CNS Diseases
  • GI Diseases
  • CVS Disorders
  • Allergy Others

• By Distribution Channel :

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa